Last edition
News about "STADA Arzneimittel AG"
STADA and Bio-Thera Secure EU Marketing Approval for Golimumab Biosimilar Gotenfia
European Commission authorises Gotenfia, referencing Simponi, for multiple autoimmune diseases across EU and EEA markets.
STADA Arzneimittel AG | 16/02/2026 | By News Bureau
Bio-Thera, STADA Expand Biosimilars Alliance to Include Tocilizumab
Bio-Thera Solutions and STADA Arzneimittel have extended their biosimilars alliance to include tocilizumab, with Bio-Thera handling development and supply while STADA secures exclusive commercialization rights across Europe and select markets.
STADA Arzneimittel AG | 25/08/2025 | By Mrinmoy Dey | 178
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy